The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.
The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.
GILAD EVRONY, MD, PHD
BENJAMIN IZAR, MD, PHD
MARTA LUKSZA, PHD
JOHN MACIEJOWSKI, PHD
KYLE K. PAYNE, PHD
DAVID SIMON, PHD
XIAOLEI SU, PHD
THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE CELEBRATES ITS 10TH ANNIVERSARY
NEW YORK, MAY 16, 2023 (Business Wire) — The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The Prize empowers investigators early in their independent careers to pursue their most exciting research projects at a critical stage when traditional funding is lacking. Recipients receive $250,000 per year for three years, totaling $750,000 per awardee.
Over the past decade, the Alliance has awarded over $40 million to 66 scientists at 13 institutions in the greater New York City area to advance their research. With this funding, investigators have been able to launch their careers, do some of their boldest and most exciting work, and uncover novel biological pathways, tools, models, and potential therapeutic approaches. In addition to funding, the Alliance provides Prize winners with opportunities to present their work to scientific and business audiences to encourage collaboration and help bridge the gap between academia and industry.
On Wednesday, June 8 the Pershing Square Sohn Cancer Research Alliance held its 2022 Prize Dinner at Bar65 at the Rainbow Room in New York, awarding its 2022 Pershing Square Sohn Prize for Young Investigators in Cancer Research to seven early-career pioneers in cancer research in the greater New York City area.
The evening began with cocktails on the terrace, followed by a seated dinner. To start the dinner, Olivia Tournay Flatto, PhD, President of The Pershing Square Foundation and Co-founder and Executive Director of the Pershing Square Sohn Cancer Research Alliance gave introductory remarks. The special guest speaker for the evening was Scientific Review Council Member Ali Brivanlou, PhD, Robert & Harriet Heilbrunn Professor at The Rockefeller University, who gave a fascinating presentation on his work with embryonic stem cells, the innovations in this space, and the ethical considerations, followed by a provocative and stimulating Q&A session. After the entrée, Scientific Review Council Member Dave Tuveson, MD, PhD, Roy J. Zuckerberg Professor of Cancer Research at Cold Spring Harbor Laboratory, introduced the seven Pershing Square Sohn Prize winners with a special video and welcomed The Pershing Square Foundation Co-Trustees William Ackman and Neri Oxman to lead the award ceremony. Prize Advisory Board 2022 Chair Jim Rothman, PhD, Sterling Professor of Cell Biology and Professor of Chemistry at Yale School of Medicine, gave concluding remarks.
Bill Ackman, Co-Founder. The Pershing Square Foundation